187 related articles for article (PubMed ID: 18004079)
21. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
[TBL] [Abstract][Full Text] [Related]
22. N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma.
Akiba J; Ogasawara S; Kawahara A; Nishida N; Sanada S; Moriya F; Kuwano M; Nakashima O; Yano H
Oncol Rep; 2008 Dec; 20(6):1329-35. PubMed ID: 19020710
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of histone deacetylase 6 contributes to accelerated migration and invasion activity of hepatocellular carcinoma cells.
Kanno K; Kanno S; Nitta H; Uesugi N; Sugai T; Masuda T; Wakabayashi G; Maesawa C
Oncol Rep; 2012 Sep; 28(3):867-73. PubMed ID: 22766642
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of metastasis-associated protein 2 is associated with hepatocellular carcinoma size and differentiation.
Lee H; Ryu SH; Hong SS; Seo DD; Min HJ; Jang MK; Kwon HJ; Yu E; Chung YH; Kim KW
J Gastroenterol Hepatol; 2009 Aug; 24(8):1445-50. PubMed ID: 19702911
[TBL] [Abstract][Full Text] [Related]
25. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.
Sumie S; Kuromatsu R; Okuda K; Ando E; Takata A; Fukushima N; Watanabe Y; Kojiro M; Sata M
Ann Surg Oncol; 2008 May; 15(5):1375-82. PubMed ID: 18324443
[TBL] [Abstract][Full Text] [Related]
26. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J
Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological and prognostic implications of arginase expression in hepatocellular carcinoma.
Mao H; Gao W; Lu G; Fang F; Teng L
Clin Lab; 2013; 59(1-2):37-43. PubMed ID: 23505904
[TBL] [Abstract][Full Text] [Related]
28. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
Lin SY; Pan HW; Liu SH; Jeng YM; Hu FC; Peng SY; Lai PL; Hsu HC
Clin Cancer Res; 2008 Aug; 14(15):4814-20. PubMed ID: 18676753
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of osteopontin independently correlates with vascular invasion and poor prognosis in patients with hepatocellular carcinoma.
Korita PV; Wakai T; Shirai Y; Matsuda Y; Sakata J; Cui X; Ajioka Y; Hatakeyama K
Hum Pathol; 2008 Dec; 39(12):1777-83. PubMed ID: 18701136
[TBL] [Abstract][Full Text] [Related]
30. Akt2 expression correlates with prognosis of human hepatocellular carcinoma.
Xu X; Sakon M; Nagano H; Hiraoka N; Yamamoto H; Hayashi N; Dono K; Nakamori S; Umeshita K; Ito Y; Matsuura N; Monden M
Oncol Rep; 2004 Jan; 11(1):25-32. PubMed ID: 14654898
[TBL] [Abstract][Full Text] [Related]
31. Chemokine receptor CCR6 as a prognostic factor after hepatic resection for hepatocellular carcinoma.
Uchida H; Iwashita Y; Sasaki A; Shibata K; Matsumoto T; Ohta M; Kitano S
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):161-8. PubMed ID: 16706828
[TBL] [Abstract][Full Text] [Related]
32. Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study.
Kawano Y; Sasaki A; Kai S; Endo Y; Iwaki K; Uchida H; Shibata K; Ohta M; Kitano S
Eur J Surg Oncol; 2009 Feb; 35(2):174-9. PubMed ID: 18325724
[TBL] [Abstract][Full Text] [Related]
33. Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma.
Fang F; Luo LB; Tao YM; Wu F; Yang LY
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):409-16. PubMed ID: 19208663
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological risk factors linked to recurrence pattern after curative hepatic resection for hepatocellular carcinoma--results of 152 resected cases.
Shirabe K; Wakiyama S; Gion T; Motomura K; Koyanagi T; Sakamoto S; Nagaie T
Hepatogastroenterology; 2007; 54(79):2084-7. PubMed ID: 18251164
[TBL] [Abstract][Full Text] [Related]
35. [Risk factors for early recurrence after surgical resection for hepatocellular carcinoma].
Park UJ; Kim YH; Kang KJ; Lim TJ
Korean J Hepatol; 2008 Sep; 14(3):371-80. PubMed ID: 18815460
[TBL] [Abstract][Full Text] [Related]
36. Expression of transforming growth factors in hepatocellular carcinoma and its relations with clinicopathological parameters and prognosis.
Lu Y; Wu LQ; Li CS; Wang SG; Han B
Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):174-8. PubMed ID: 18397854
[TBL] [Abstract][Full Text] [Related]
37. Tumor-associated lymphangiogenesis correlates with prognosis after resection of human hepatocellular carcinoma.
Thelen A; Jonas S; Benckert C; Weichert W; Schott E; Bötcher C; Dietz E; Wiedenmann B; Neuhaus P; Scholz A
Ann Surg Oncol; 2009 May; 16(5):1222-30. PubMed ID: 19224279
[TBL] [Abstract][Full Text] [Related]
38. Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection.
Yang LY; Fang F; Ou DP; Wu W; Zeng ZJ; Wu F
Ann Surg; 2009 Jan; 249(1):118-23. PubMed ID: 19106686
[TBL] [Abstract][Full Text] [Related]
39. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
Yang XR; Xu Y; Shi GM; Fan J; Zhou J; Ji Y; Sun HC; Qiu SJ; Yu B; Gao Q; He YZ; Qin WZ; Chen RX; Yang GH; Wu B; Lu Q; Wu ZQ; Tang ZY
Clin Cancer Res; 2008 Jun; 14(12):3850-9. PubMed ID: 18559605
[TBL] [Abstract][Full Text] [Related]
40. Expression of E- and N-cadherin and clinicopathology in hepatocellular carcinoma.
Cho SB; Lee KH; Lee JH; Park SY; Lee WS; Park CH; Kim HS; Choi SK; Rew JS
Pathol Int; 2008 Oct; 58(10):635-42. PubMed ID: 18801083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
